Panel Discussion: Manufacturing Leaner & More Affordably to Accelerate Cell Therapy Development in Europe

• Identify key cost drivers in cell therapy manufacturing and discuss practical strategies to reduce them without compromising quality
• Debate approaches to efficient scale-out and scale-up that enable broader patient access while meeting regulatory and quality standards

Speakers:

Frederik De Vos

Senior Director Quality Operations, Advanced Therapies Platform

Johnson & Johnson

Ali Mohamed

Senior Vice President, CMC

Immatics

Sarah Yuan

Chief Technology Officer

Cabaletta Bio